Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Idelalisib+Obinutuzumab in Patients With Relapsed/Refractory Follicular Lymphoma

Fondazione Italiana Linfomi - ETS · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
follicular lymphoma, idelalisib, obinutuzumab, relapsed/refractory follicular lymphoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 804986
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.